Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
about
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosisMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeMyelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.Defining distinct features of anti-MOG antibody associated central nervous system demyelination.MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.Diagnosis and Treatment of NMO Spectrum Disorder and MOG-EncephalomyelitisOptical coherence tomography in central nervous system demyelinating diseases related optic neuritis
P2860
Q29036090-87E4A7EC-4A19-4F85-B203-C5B4914A6082Q30371412-58F1681F-20DB-4FDC-A0FB-C7932E301E7BQ33645795-40411718-C476-4C60-8421-2593D9E33536Q33831179-6C40A0A7-67D2-416D-B1A1-04D2D9308229Q37374434-833E9A60-0A15-4E6E-96D0-BC4178D01725Q37383474-1293D4C3-2DB9-4BC9-AC41-8BED8753B9BAQ37383555-B542DED7-A602-4768-BB0B-470A737EE628Q40066335-C5786F16-495F-4BB2-B0B1-0E2A69A93DC5Q40281523-2E15406C-6995-4CAC-BBA7-6E0BE8F8611FQ41877972-66196852-C332-429B-8CE0-1106D9A90651Q42627948-12987737-CC23-4869-AA45-429D5EDE4B09Q48235947-2A3BC189-52D9-423E-B280-CC882CD476E2Q50194965-CA041968-4868-4374-B54B-B4058BA6A617Q51327401-56A7BF64-3323-4AA5-91EA-CCC43C0EAD5DQ52603606-0721AEB1-E780-45F7-8D45-0C924D44E5AAQ52803391-A84CA73F-3430-427D-954A-FBBE72A6DF50Q55221002-47F55C00-EF33-449E-8651-E93478E7092AQ58573155-A1DAF59A-6301-4550-8AC0-0BA86F8EB04FQ58597236-A090C5EA-E8E5-44E9-B446-B31491D8C8E9
P2860
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@ast
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@en
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@nl
type
label
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@ast
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@en
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@nl
prefLabel
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@ast
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@en
Screening for MOG-IgG and 27 o ...... gs in a MOG-IgG-positive case.
@nl
P2093
P2860
P356
P1476
Screening for MOG-IgG and 27 o ...... ngs in a MOG-IgG-positive case
@en
P2093
Brigitte Wildemann
Fatima Barbara König
Friedemann Paul
Klemens Ruprecht
Sven Jarius
Wolfgang Brück
P2860
P304
P356
10.1177/1352458515622986
P577
2016-02-11T00:00:00Z